To Top

Search By Topic

Contract Development and Manufacturing (CDMO)

344 Articles available
Drug Development

Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge

PR-M02-18-NI-79
Clinical Trials

Breakthrough Scar Treatment in Clinical Trials

PAO-M02-18-NI-016
Strategic Collaboration

Bristol-Myers Squibb and Nektar Therapeutics Announce Global Development & Commercialization Collaboration for Nektar’s CD122-biased Agonist, NKTR-214

PR-M02-18-NI-73
Approval

Celltrion Receives EU Approval for Trastuzumab Biosimilar

PR-M02-18-NI-71
Cell Culture Portfolio

Lonza Expands Cell-Culture Portfolio with Quasi Vivo ® System

PR-M02-18-NI-59
SCRS' Global Impact Partner Program

Boehringer Ingelheim Demonstrates their Commitment to Site Relationships by Joining SCRS' Global Impact Partner Program

PR-M02-18-NI-56
Dermatology

Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual Meeting

PR-M02-18-NI-54
Strategic Collaboration

Sirenas Enters Into Multi-Target Collaboration With Bristol-Myers Squibb

PR-M02-18-NI-55
Inhalation

Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol

PR-M02-18-NI-53
Growth

Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

PR-M02-18-NI-63
Strategic Partnership

ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody

PR-M02-18-NI-64
Generics

Teva Announces Launch of a Generic Version of Syprine® in the United States

PR-M02-18-NI-050
FDA Approval

Pii and Its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017

PR-M02-18-NI-048
Strategic Partnership

Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines

PR-M02-18-NI-047
Acquistion

Allergen Acquires Elastagen

PAO-M02-18-NI-012
Launch

WuXi AppTec Launches Advanced Library Compound Initiative on LabNetwork.com

PR-M02-18-NI-039
Award

Thermo Fisher Scientific Wins CiteAb 2018 Award for its Antibody Validation Initiative

PR-M02-18-NI-040
Strategic Partnership

AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area

PR-M02-18-NI-037
Clinical Trials

Tyzivumab is Ready for Trials

PAO-M02-18-NI-011
Biomanufacturing

Amgen to Open Biomanufacturing Plant in the US

PAO-M02-18-NI-010
Packaging

SCHOTT AG, ARaymondlife and Vanrx Pharmasystems announce product compatibility for primary packaging of sterile injectables

PR-M02-18-NI-035
Marketing

Evonik Launches a New MetAMINO® Marketing Campaign to the Middle East and African Markets At VIV MEA in Abu Dhabi

PR-M02-18-NI-033
Launch

Thermo Fisher Scientific Launches Axiom Microbiome Array for Research

PR-M02-18-NI-032
Acquistion

Celanese Completes Omni Acquisition

PAO-M02-18-NI-009
Investment

Polpharma Group Gets Digital

PAO-M02-18-NI-008
CDMO

Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO

PR-M02-18-NI-030
Acquistion

Celgene Corporation Commences Tender Offer for Juno Therapeutics, Inc.

PR-M02-18-NI-026
Generic

Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva® Tablets

PR-M02-18-NI-025
Appointment

PPD Names Maria Teresa Hilado, CFO of Allergan, to its Board of Directors

PR-M02-18-NI-023
Joint Venture

DSM and Evonik Establish Veramaris Joint Venture

PR-M02-18-NI-024
Acquistion

Partner Therapeutics (PTx) Acquires Leukine® from Sanofi

PR-M02-18-NI-021
Investment

Dracen Pharmaceuticals Raises Over $40 million

PAO-M02-18-NI-007
Drug Development

Mylan and Theravance Will Receive FDA Decision on COPD Drug by November

PAO-M02-18-NI-006
Immuno-Oncology

Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca

PR-M02-18-NI-020
CEO

Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer

PR-M02-18-NI-018
Investment

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

PR-M02-18-NI-017
Leadership

Avara Pharmaceutical Services Wins CMO Leadership Awards in All 6 Categories for Contract Manufacturing

PR-M02-18-NI-016
Expanded Capacity

Cambrex Expands Process Research and Development Capabilities Across North America

PR-M02-18-NI-014
IND Application

WuXi Biologics Congratulates BioAtla on FDA Clearance of IND Application for CAB-AXL-ADC

PR-M02-18-NI-011
Healthcare

Leading Companies Taking Action to Address Healthcare

PAO-M02-18-NI-005
Animal Nutrition

Versamaris JV Formed by DSM and Evonik

PAO-M02-18-NI-004
Oncology

Stand Up To Cancer Announces $11M Collaborative, Multi-Disciplinary Research Program

PR-M02-18-NI-010
Partnership

Agilent Partners with Science Exchange

PR-M02-18-NI-009
Strategic Collaboration

WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500

PR-M02-18-NI-007
Agreement

BioDuro Announces Cooperation Agreement with Porton Pharma Solutions

PR-M02-18-NI-006
Fast Track

FDA Grants Fast Track Status to Takeda’s Zika Vaccine Candidate

PAO-M02-18-NI-003
New Drug Application

Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease

PR-M02-18-NI-005
Distribution

Nexeo Solutions Announces New Distribution Agreement in Mexico for BASF Personal Care

PR-M02-18-NI-004
Laboratory

New, Automated UV-Visible Spectrophotometers are Designed for Today's Modern Lab

PR-M02-18-NI-002
Forecast

Biotechnology Companies Prepared for a Big 2018

PR-M01-18-NI-099
Drug Development

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban

PR-M01-18-NI-097
Drug Development

Janssen to Present 14 Abstracts in Prostate and Urothelial Cancers at ASCO GU 2018

PR-M01-18-NI-095
Vaccine

EMA Committee Gives Positive Recommendation to GSK’s Shingles Vaccine

PAO-M01-18-NI-046
Market Insight

Global Stroke Management Market Expected to Reach $36,756 million by 2023 — Allied Market Research

PR-M01-18-NI-092
Efficacy

Efficacy Testing Market Worth 501.6 Million USD by 2022

PR-M01-18-NI-090
Strategic Partnership

Biocartis & Immunexpress Sign Partnership for a Sepsis Host Immune Response Test on the Idylla™ platform

PR-M01-18-NI-094
Market Prediction

Focal Segmental Glomerulosclerosis Market to Reach US$15.83 Billion by 2025, Globally: Transparency Market Research

PR-M01-18-NI-093
CAR-T

Pfizer Joins Gilead in CAR-T Development   

PAO-M01-18-NI-044
FDA

FDA and DoD Launch Joint Program to Accelerate Drug Development

PAO-M01-18-NI-043
Strategic Partnership

WuXi Partners with Swedish Firm to Establish New Contract Manufacturer

PAO-M01-18-NI-043
Capacity Expansion

Paragon Bioservices Announces New Commercial Manufacturing Facility Expansion

PR-M01-18-NI-087
Drug Discovery

X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca

PR-M01-18-NI-073
Launch

GSK Launches Three-in-One HIV Pill in China

PAO-M01-18-NI-040
Acqusition

Celgene Confirms $9 Billion Buyout of Juno Therapeutics

PAO-M01-18-NI-039
Inhalation

Hovione strengthens Inhalation Services portfolio

PR-M01-18-NI-084
Strategic Collaboration

NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology

PR-M01-18-NI-075
Appointment

UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer

PR-M01-18-NI-076
Medical Device

AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M West 2018

PR-M01-18-NI-069
Launch

Roche launches CE-marked VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer

PR-M01-18-NI-068
Oncology

Merck's KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment

PR-M01-18-NI-063
Innovation

Harvard Researchers Use Chip Technology to Investigate New Anti-inflammatory Drugs

PAO-M01-18-NI-034
Supplier

Abzena Selects Sartorius Stedum Biotech as Supplier of Single-Use Tech

PAO-M01-18-NI-033
Merger

CMC Biologics Becomes AGC Biologics

PAO-M01-18-NI-032
Launch

DSM Sinochem Pharmaceuticals successfully launches Rosuvastatin finished dosage formulation in Western Europe

PR-M01-18-NI-054
Partnership

Boehringer Ingelheim and Adimab Partner on Antibodies

PAO-M01-18-NI-030
Rights Acquisition

Nuvo Pharmaceuticals (Ireland) Limited Acquires U.S. Product Rights to Resultz® from Piedmont Pharmaceuticals LLC

PR-M01-18-NI-055
Digital Platform

Clinical Decision-support Software to be Developed by Roche and GE Healthcare

PAO-M01-18-NI-028
Acquisition

Impact Biomedicines Acquired By Celgene

PAO-M01-18-NI-027
Expansion

Abzena Continues to Expand Globally

PAO-M01-18-NI-025
Cardiovascular

Secant Group Develops the First Synthetic Regenerative Cardiovascular Graft

PR-M01-18-NI-052
Flexible Manufacturing

Thermo Fisher Scientific Designs Flexible Manufacturing Site for Flexion Therapeutics, Inc.

PR-M01-18-NI-041
CDMO

Pulmonx Submits Premarket Approval (PMA) Application to U.S. FDA for Zephyr Endobronchial Valve as Treatment for Emphysema

PR-M01-18-NI-039
CDMO

1Vision Awarded Home Telehealth Contract from the U.S. Department of Veterans Affairs

PR-M01-18-NI-038
Product Pipeline

Moderna Announces 19 Development Candidates at JPM

PAO-M01-18-NI-021
Clinical Trials

BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC

PR-M01-18-NI-035
Bioequivalence Study

Biohaven Announces Positive Results From Bioequivalence Study With Sublingual BHV-0223 Zydis® Orally Dissolving Tablet

PR-M01-18-NI-034
Strategic Collaboration

Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology

PR-M01-18-NI-033
Development Agreement

Arvinas Protein Degradation Technology Attracts Pfizer’s Attention

PAO-M01-18-NI-020
M&A

Ignyta Snapped up by Roche

PAO-M01-18-NI-019
FDA

FDA Still Addressing Drug Shortages Resulting from Manufacturing Disruptions in Puerto Rico

PAO-M01-18-NI-018
Acquistion

Mallinckrodt Expands Rare Disease Pipeline with Sucampo Acquisition

PAO-M01-18-NI-017
Joint Venture

WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services

PR-M01-18-NI-027
Cannibis

California Legalizes Cannabis with Canada Looming

PR-M01-18-NI-030
Drug Development

Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

PR-M01-18-NI-029
Oncology Research

Global BioLife, a Biomedical Subsidiary of Singapore eDevelopment Limited, Completes Cancer Research for New Universal Therapeutic Drug Platform

PR-M01-18-NI-028
Announcement

Taxus Cardium Announces Name Change To Gene Biotherapeutics

PR-M01-18-NI-021
Drug Development

Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs

PR-M01-18-NI-024
Big Data

Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available 'Big Data' Human Sequencing Resource with UK Biobank

PR-M01-18-NI-020
Expansion

Recipharm Expands Stake in India

PAO-M01-18-NI-016
Licensing Agreement

Generex Biotech and Shenzhen BioScien Enter into Licensing Agreement

PAO-M01-18-NI-014
CFDA

China FDA Publishes Guidance for Priority Review

PAO-M01-18-NI-013
Transition

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

PR-M01-18-NI-017
CDMO

Intec Pharma Announces Development Collaboration With Global Pharmaceutical Company

PR-M01-18-NI-019
CDMO

Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

PR-M01-18-NI-014
Breakthrough Therapy

AbbVie's Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis

PR-M01-18-NI-018
Drug Development

PPD® Laboratories Named a Top Innovator in Drug Development

PR-M01-18-NI-016
CDMO

Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases

PR-M01-18-NI-015
Hires

AMRI Names Michael Mulhern as Chief Executive Officer

PR-M01-18-NI-012
Drug Development

Promacta Gets Breakthrough Therapy Designation

PAO-M01-18-NI-012
Biologics

New Class of Exosome Biologics Focuses on Stroke Treatment

PAO-M01-18-NI-011
Drug Discovery

Defense Department Commits $16 Million to Fight Bacterial Bioweapons

PAO-M01-18-NI-010
Immunotherapy

Deal with Inovio Launches ApolloBio’s Commercialization Plans in China

PAO-M01-18-NI-009
Agreement

Orbis Biosciences Announces Licensing Agreement with Reckitt Benckiser

PR-M01-18-NI-011
Partnership

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites in San Diego and Bristol

PR-M01-18-NI-011
Drug Development

Array BioPharma Forms New Subsidiary Yarra Therapeutics

PAO-M01-18-NI-007
CAR T

Thermo Fisher Gets Key Customer for Its Cell Therapy Activation Reagents

PAO-M01-18-NI-006
Cell and Gene Therapy

FDA Approves Gene Therapy

PAO-M01-18-NI-005
FDA Guidance

FDA Received Numerous Comments on Its Draft Guidance for Evaluating Biosimilarity

PAO-M01-18-NI-004
Research

Gilead Makes $100 Million Commitment to Fighting HIV/AIDs

PAO-M12-17-NI-038
Research

Tumor Killing Combo Wins Third U.S. Patent

PAO-M12-17-NI-033
Oncology

CMC Biologics Announces Agreement

PAO-M12-17-NI-032
Drug Development

Chinese Biopharma Receives Series A Financing

PAO-M12-17-NI-031
Strategic Partnership

BioVectra and Keryx Expand Strategic API Supply Relationship

PAO-M12-17-NI-030
Added Capacity

World’s Largest Biologics Plant Gets EMA Nod

PAO-M12-17-NI-029
Innovation

Renova Therapeutics' Gene Transfer Tech Enters the Fast Lane

PAO-M12-17-NI-028
Clinical Trials

Novo Nordisk Bags FDA Approval for New Diabetes Treatment

PAO-M12-17-NI-024
FDA

New FDA Draft Guidance Intended to Accelerate Development of Drugs for Rare Pediatric Diseases

PAO-M12-17-NI-023
Drug Development

New Generic for Kenalog-40 Approved

PAO-M12-17-NI-020
3D Printing

Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs

PAO-M12-17-NI-018
Hemophilia

Results of New Gene Therapy Revealed at Hemophilia Meeting

PAO-M12-17-NI-017
Drug Development

ZUMA-1 Study of Yescarta Reports 58% Complete Remission

PAO-M12-17-NI-016
Oncology

Holiday Program Brings Hope Home to Lung Cancer Patients

PR-M12-17-NI-002
Over-the-Counter

Men in the UK Will Be Able to Buy Viagra Over the Counter Next May

PAO-M12-17-NI-013
//Fix for text overflow in cards